This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1981 Jul;55(1):1-18.

doi: 10.3171/jns.1981.55.1.0001.

Immunological aspects of intrinsic glial tumors

M L Apuzzo, M S Mitchell

PMID: 7017079
DOI: 10.3171/jns.1981.55.1.0001

Review

Immunological aspects of intrinsic glial tumors

M L Apuzzo et al. J Neurosurg. 1981 Jul.

. 1981 Jul;55(1):1-18.

doi: 10.3171/jns.1981.55.1.0001.

Authors

M L Apuzzo, M S Mitchell

PMID: 7017079
DOI: 10.3171/jns.1981.55.1.0001

No abstract available

PubMed Disclaimer

Similar articles

Immunobiology of human gliomas.
Bullard DE, Gillespie GY, Mahaley MS, Bigner DD. Bullard DE, et al. Semin Oncol. 1986 Mar;13(1):94-109. Semin Oncol. 1986. PMID: 2420011 Review. No abstract available.
Immunobiologic aspects of the brain and human gliomas. A review.
Wikstrand CJ, Bigner DD. Wikstrand CJ, et al. Am J Pathol. 1980 Feb;98(2):517-68. Am J Pathol. 1980. PMID: 6986786 Free PMC article. Review. No abstract available.
Glioma antigen.
Toda M. Toda M. Adv Exp Med Biol. 2012;746:77-84. doi: 10.1007/978-1-4614-3146-6_6. Adv Exp Med Biol. 2012. PMID: 22639160 Review.
[Cellular immunotherapy for malignant glioma].
Okamoto Y, Yamashita J. Okamoto Y, et al. Nihon Rinsho. 2005 Sep;63 Suppl 9:557-62. Nihon Rinsho. 2005. PMID: 16201581 Review. Japanese. No abstract available.
Immunology of human brain tumors.
Coakham HB. Coakham HB. Eur J Cancer Clin Oncol. 1984 Jan;20(1):145-9. doi: 10.1016/0277-5379(84)90046-4. Eur J Cancer Clin Oncol. 1984. PMID: 6363093 Review. No abstract available.

See all similar articles

Cited by

Association of malignant glioma with the human leukocyte antigen, HLA-A24(9).
Nitta T, Ebato M, Sato K. Nitta T, et al. Neurosurg Rev. 1994;17(3):211-5. doi: 10.1007/BF00418435. Neurosurg Rev. 1994. PMID: 7838400
Mechanisms by which human gliomas may escape cellular immune attack.
Gately MK, Glaser M, McCarron RM, Dick SJ, Dick MD, Mettetal RW Jr, Kornblith PL. Gately MK, et al. Acta Neurochir (Wien). 1982;64(3-4):175-97. doi: 10.1007/BF01406052. Acta Neurochir (Wien). 1982. PMID: 6215833
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.
Quattrocchi KB, Miller CH, Cush S, Bernard SA, Dull ST, Smith M, Gudeman S, Varia MA. Quattrocchi KB, et al. J Neurooncol. 1999;45(2):141-57. doi: 10.1023/a:1006293606710. J Neurooncol. 1999. PMID: 10778730 Clinical Trial.
Immunology of gliomas.
de Tribolet N. de Tribolet N. Childs Nerv Syst. 1989 Apr;5(2):60-5. doi: 10.1007/BF00571111. Childs Nerv Syst. 1989. PMID: 2660987 Review.
Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.
Merchant RE, Ellison MD, Young HF. Merchant RE, et al. J Neurooncol. 1990 Apr;8(2):173-88. doi: 10.1007/BF00177842. J Neurooncol. 1990. PMID: 2193121 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Sheridan PubFactory
Medical
- MedlinePlus Health Information